Treatment preference and tolerability with alendronate once weekly over a 3-month period: An Israeli multi-center study

Keyphrases

• Israeli 100%
• Treatment Preferences 100%
• Alendronate 100%
• Once-weekly 100%
• Treatment Tolerability 100%
• Once a Day 33%
• Osteoporosis 26%
• Patient Preference 13%
• Postmenopausal Women 13%
• Daily Dose 13%
• Relative Preferences 13%
• Dosing Regimen 13%
• Weekly Regimen 13%
• Israel 6%
• Adverse Events 6%
• Appropriate Treatment 6%
• Long-term Treatment 6%
• Intolerant 6%
• Chronic Conditions 6%
• Primary Care 6%
• Community Clinics 6%
• Intolerance 6%
• Multicenter Trial 6%
• Previous Treatment 6%
• Physician Preference 6%
• Postmenopausal Osteoporosis 6%
• Community of Care 6%
• Daily Treatment 6%
• Once-daily Dosing 6%
• Continuation Treatment 6%
• Dosing Instructions 6%
• Physician Satisfaction 6%
• Weekly Dosing 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Tolerability 100%
• Alendronic Acid 100%
• Adverse Event 6%